Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Sienna Biopharmaceuticals, Inc. (SNNAQ) had Debt to Equity Ratio of 1.13 for the most recently reported fiscal year, ending 2018-12-31.
| Income Statement Financials | |
-- |
|
$-73.47M |
|
-- |
|
-- |
|
$76.50M |
|
$-76.50M |
|
$3.03M |
|
$-73.47M |
|
$-73.47M |
|
$-73.47M |
|
$-73.47M |
|
$-73.47M |
|
$-73.47M |
|
$-76.50M |
|
$-76.08M |
|
20.45M |
|
20.45M |
|
$-3.59 |
|
$-3.59 |
|
| Balance Sheet Financials | |
$50.41M |
|
$0.31M |
|
$56.89M |
|
$107.31M |
|
$24.35M |
|
$30.12M |
|
$56.38M |
|
$80.72M |
|
$26.58M |
|
$15.59M |
|
$26.58M |
|
20.87M |
|
| Cash Flow Statement Financials | |
$-61.69M |
|
$-0.04M |
|
$35.96M |
|
$74.65M |
|
$48.71M |
|
$-25.94M |
|
$4.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
0.53 |
|
|
Debt to Equity Ratio |
1.13 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-276.40% |
|
-471.21% |
|
-68.47% |
|
-129.56% |
|
$1.27 |
|
$-3.02 |
|
$-3.02 |
|